In Australia, hepatitis C infections are largely attributable to unsafe injecting drug use practices, with people who inject drugs representing approximately 90% of newly acquired infections. Medical staff in Drug and Alcohol settings play an important role in improving the health outcomes of people living with Hepatitis C and can reduce a patient’s risk of developing advanced liver disease through early diagnosis, thorough evaluation and assessment of liver disease severity, appropriate management of co-morbidities and treatment with newly available drug regimens.
- Interpret test results and diagnose hepatitis C appropriately
- Ensure that people at risk of hepatitis C infection are regularly screened
- Manage and monitor people with chronic hepatitis C suitably, including staging of liver disease and lifestyle modifications as needed
- Advise patients about new therapies for hepatitis C so they can make informed treatment decisions
This course is FREE. Dinner and refreshments will be provided.
Funding for this course has been provided by the Department of Health.
This course will be targeted towards GPs, nurses, and allied health staff who are interested in preparing clients for interferon-free DAA HCV therapy in the drug and alcohol treatment setting.